Showing results (551-560 of 579) with videos related to
Sort By:
Pageof 58
American Journal of Hematology|September 2, 2022
Contemporary outcomes in IDH-mutated acute myeloid leukemia: The impact of co-occurring NPM1 mutations and venetoclax-based treatmentCurtis A Lachowiez, Patrick K Reville, Hagop Kantarjian, et al.Blood Cancer Discovery|March 8, 2021
Patterns of Resistance Differ in Patients with Acute Myeloid Leukemia Treated with Type I versus Type II FLT3 inhibitorsAhmad S Alotaibi, Musa Yilmaz, Rashmi Kanagal-Shamanna, et al.Brain : a Journal of Neurology|June 11, 2005
The fragile X tremor ataxia syndrome in the differential diagnosis of multiple system atrophy: data from the EMSA Study GroupC Kamm, D G Healy, N P Quinn, et al.Journal of Hematology & Oncology|October 9, 2020
Outcomes with sequential FLT3-inhibitor-based therapies in patients with AMLMusa Yilmaz, Mansour Alfayez, Courtney D DiNardo, et al.American Journal of Hematology|February 8, 2025
Clinico-Genomic Interrogation of Secondary-Type Acute Myeloid Leukemia: Response and Outcomes to Contemporary TherapiesJayastu Senapati, Sanam Loghavi, Jennifer Marvin-Peek, et al.Cancer|May 6, 2026
Prognostic impact of ASXL1 mutations in acute myeloid leukemia treated with lower intensity therapyJennifer Marvin-Peek, Courtney D DiNardo, Sanam Loghavi, et al.Cancer|August 7, 2025
Contemporary outcomes of octa-nonagenarians with newly diagnosed acute myeloid leukemiaJayastu Senapati, Hagop M Kantarjian, Tapan M Kadia, et al.JCO Precision Oncology|December 10, 2025
Clinical Outcomes of Adult Patients With Newly Diagnosed Mixed Phenotype Acute LeukemiaHannah Goulart, Farhad Ravandi, Nicholas J Short, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 15, 2022
Phase II Study of Venetoclax Added to Cladribine Plus Low-Dose Cytarabine Alternating With 5-Azacitidine in Older Patients With Newly Diagnosed Acute Myeloid LeukemiaTapan M Kadia, Patrick K Reville, Xuemei Wang, et al.American Journal of Hematology|April 26, 2026
Cladribine With Low-Dose Cytarabine and Venetoclax Alternating With Azacitidine and Venetoclax for Newly Diagnosed Acute Myeloid LeukemiaTapan M Kadia, Alex Bataller, Alexandre Bazinet, et al.Pageof 58